[go: up one dir, main page]

FI935350A0 - Transdermala farmaceutiska kompositioner innehaollande 4-substituerade imidazoler - Google Patents

Transdermala farmaceutiska kompositioner innehaollande 4-substituerade imidazoler

Info

Publication number
FI935350A0
FI935350A0 FI935350A FI935350A FI935350A0 FI 935350 A0 FI935350 A0 FI 935350A0 FI 935350 A FI935350 A FI 935350A FI 935350 A FI935350 A FI 935350A FI 935350 A0 FI935350 A0 FI 935350A0
Authority
FI
Finland
Prior art keywords
pct
imidazole
substituents
pharmaceutical composition
composition comprises
Prior art date
Application number
FI935350A
Other languages
English (en)
Finnish (fi)
Other versions
FI935350L (fi
FI935350A7 (fi
Inventor
Harry Jalonen
Risto Lammintausta
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of FI935350A0 publication Critical patent/FI935350A0/fi
Publication of FI935350L publication Critical patent/FI935350L/fi
Publication of FI935350A7 publication Critical patent/FI935350A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI935350A 1991-05-31 1992-05-27 4-substituoituja imidatsoleja sisältävät transdermaaliset farmaseuttis et koostumukset FI935350A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9111773A GB2256135B (en) 1991-05-31 1991-05-31 Transdermal administration of 4-substituted imidazoles
PCT/FI1992/000166 WO1992021334A1 (en) 1991-05-31 1992-05-27 Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally

Publications (3)

Publication Number Publication Date
FI935350A0 true FI935350A0 (fi) 1993-11-30
FI935350L FI935350L (fi) 1993-11-30
FI935350A7 FI935350A7 (fi) 1993-11-30

Family

ID=10695905

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935350A FI935350A7 (fi) 1991-05-31 1992-05-27 4-substituoituja imidatsoleja sisältävät transdermaaliset farmaseuttis et koostumukset

Country Status (18)

Country Link
US (1) US5464628A (lt)
EP (1) EP0586467B1 (lt)
JP (1) JP3269822B2 (lt)
AT (1) ATE199317T1 (lt)
AU (1) AU1780892A (lt)
CA (1) CA2110162C (lt)
DE (1) DE69231709T2 (lt)
DK (1) DK0586467T3 (lt)
EE (1) EE02994B1 (lt)
ES (1) ES2154636T3 (lt)
FI (1) FI935350A7 (lt)
GB (1) GB2256135B (lt)
GR (1) GR3035499T3 (lt)
IE (1) IE66188B1 (lt)
LT (1) LT3005B (lt)
LV (1) LV10042B (lt)
NO (1) NO307365B1 (lt)
WO (1) WO1992021334A1 (lt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6821196A (en) * 1995-08-14 1997-03-12 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
TW200930291A (en) 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
JP5043664B2 (ja) * 2004-12-15 2012-10-10 帝國製薬株式会社 エトフェナマート含有外用貼付剤
ATE458732T1 (de) 2006-01-27 2010-03-15 Hoffmann La Roche Verwendung von 4-imidazol-derivaten für zns- erkrankungen
WO2008017591A1 (en) * 2006-08-08 2008-02-14 Intervet International B.V. Composition for enhanced antiparasitic activity
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
WO2020016827A1 (en) * 2018-07-18 2020-01-23 Clexio Biosciences Ltd. Purified crystalline detomidine hydrochloride monohydrate, anhydrate and free base with low amounts of iso-detomidine and other impurities by recrystallisation in water
AU2020264808B2 (en) 2019-05-01 2025-01-02 Clexio Biosciences Ltd. Methods of treating pruritus
CN112220767B (zh) * 2020-09-25 2022-10-25 安徽省公众检验研究院有限公司 一种盐酸阿替美唑缓释片的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4672344A (en) 1985-04-19 1987-06-09 Siemens Aktiengesellschaft Polarized electromagnetic relay
FI864570A0 (fi) 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
CA2110162C (en) 2002-11-12
US5464628A (en) 1995-11-07
DK0586467T3 (da) 2001-03-26
GB9111773D0 (en) 1991-07-24
NO934261L (no) 1993-11-25
IE66188B1 (en) 1995-12-13
LT3005B (lt) 1994-08-25
NO307365B1 (no) 2000-03-27
AU1780892A (en) 1993-01-08
EE02994B1 (et) 1997-06-16
LV10042B (en) 1995-02-20
IE921938A1 (en) 1992-12-02
FI935350L (fi) 1993-11-30
EP0586467A1 (en) 1994-03-16
EP0586467B1 (en) 2001-02-28
JP3269822B2 (ja) 2002-04-02
DE69231709T2 (de) 2001-10-04
GB2256135B (en) 1995-01-18
GB2256135A (en) 1992-12-02
ATE199317T1 (de) 2001-03-15
NO934261D0 (no) 1993-11-25
GR3035499T3 (en) 2001-06-29
LV10042A (lv) 1994-05-10
LTIP111A (lt) 1994-03-25
WO1992021334A1 (en) 1992-12-10
FI935350A7 (fi) 1993-11-30
JPH06507618A (ja) 1994-09-01
CA2110162A1 (en) 1992-12-10
ES2154636T3 (es) 2001-04-16
DE69231709D1 (de) 2001-04-05

Similar Documents

Publication Publication Date Title
FI935350A0 (fi) Transdermala farmaceutiska kompositioner innehaollande 4-substituerade imidazoler
BE904226A (fr) Derives 4-substitues d'androst-4-ene-3,17-dione utiles notamment comme inhibiteurs d'aromatase et leur fabrication.
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
ES8300678A1 (es) Procedimiento de preparacion de derivados de 1-fenil-1-hi- droxi-etilamina
HUP9801749A2 (hu) Nodulisporinsavszármazékok és az ezeket tartalmazó gyógyszerkészítmények
DK0779886T3 (da) Dihydrobenzofuran og beslægtede forbindelser, der er anvendelige som antiinflammatoriske midler
GB1536515A (en) Compositions containing silicon derivatives
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
GR3023107T3 (en) New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them.
KR890016017A (ko) 치환된 1-(1h-이미다졸-4-일)알킬-벤즈아미드
ES8800142A1 (es) Un procedimiento para preparar un derivado de semicarbazida
FI104071B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
NO173057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater
DK0635012T3 (da) Bis-aryl-carbinolderivater uden broer, præparater indeholdende disse og fremgangsmåder til anvendelse af disse
PT832067E (pt) Processo para a conversao de 2,4-dicloropiridinas a 2-ariloxi-4-cloropiridinas
GB1033920A (en) Novel derivatives of triphenylethanols
MY104540A (en) Pharmaceutical preparations.
KR950702830A (ko) 치환된 아자스피란을 사용한 건선 치료 방법(methods of treating psoriasis employing substituted azaspiranes)
BE899918A (fr) Amides d'acides carboxyliques et leurs derives, leur preparation et leur application en therapeutique.